159
Views
24
CrossRef citations to date
0
Altmetric
Original Research

The safety profile of parecoxib for the treatment of postoperative pain: a pooled analysis of 28 randomized, double-blind, placebo-controlled clinical trials and a review of over 10 years of postauthorization data

, , &
Pages 2451-2459 | Published online: 10 Oct 2017

References

  • DwivediAKGurjarVKumarSSinghNMolecular basis for non specificity of nonsteroidal anti-inflammatory drugs (NSAIDs)Drug Discov Today201520786387325794602
  • RouzerCAMarnettLJCyclooxygenases: structural and functional insightsJ Lipid Res200950SupplS29S3418952571
  • RamsayMAAcute postoperative pain managementProc (Bayl Univ Med Cent)200013324424716389390
  • The American Society of Anesthesiologists Task Force on Acute Pain ManagementPractice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain ManagementAnesthesiology2012116224827322227789
  • SchugSAThe role of COX-2 inhibitors in the treatment of postoperative painJ Cardiovasc Pharmacol200647Suppl 1S82S8616785836
  • SchaferAIEffects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasisJ Clin Pharmacol19953532092197608308
  • Hernandez-DiazSRodriguezLAAssociation between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990sArch Intern Med2000160142093209910904451
  • AllisonMCHowatsonAGTorranceCJLeeFDRussellRIGastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugsN Engl J Med1992327117497541501650
  • HawkeyCJCOX-1 and COX-2 inhibitorsBest Pract Res Clin Gastroenterol200115580182011566042
  • WeirMRRenal effects of nonselective NSAIDs and coxibsCleve Clin J Med200269Suppl 1SI53S5812086295
  • RostomAMuirKDubeCGastrointestinal safety of cyclooxygenase-2 inhibitors: a cochrane collaboration systematic reviewClin Gastroenterol Hepatol20075781882817556027
  • MooreRADerrySMcQuayHJCyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular riskBMC Musculoskelet Disord2007817317683540
  • LeesePTHubbardRCKarimAEffects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trialJ Clin Pharmacol200040212413210664917
  • NoveckRLaurentAKussMTalwalkerSHubbardRParecoxib sodium does not impair platelet function in healthy elderly and non-elderly individualsClin Drug Investig2001217465476
  • MurrayMDBraterDCRenal toxicity of the nonsteroidal anti-inflammatory drugsAnnu Rev Pharmacol Toxicol19933314354658494347
  • BelloAEHoltRJCardiovascular risk with non-steroidal anti-inflammatory drugs: clinical implicationsDrug Saf2014371189790225079141
  • KowalskiMLMakowskaJSSeven steps to the diagnosis of NSAIDs hypersensitivity: how to apply a new classification in real practice?Allergy Asthma Immunol Res20157431232025749768
  • OrtegaNDonaIMorenoEPractical guidelines for diagnosing hypersensitivity reactions to nonsteroidal anti-inflammatory drugsJ Investig Allergol Clin Immunol2014245308323
  • WheltonAHamiltonCWNonsteroidal anti-inflammatory drugs: effects on kidney functionJ Clin Pharmacol19913175885981894754
  • PatronoCBaigentCNonsteroidal anti-inflammatory drugs and the heartCirculation2014129890791624566065
  • SherveKGerardCJNeherJOAnnaLStCardiovascular effects of NSAIDsAm Fam Physician2014904 Online
  • European Medicines AgencySummary of product characteristics Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000381/WC500038843.pdfAccessed September 19, 2015
  • Pfizer AustraliaDynastat prescribing information Available from: http://www.pfizer.com.au/sites/g/files/g10005016/f/201311/PI_Dynastat_306.pdfAccessed September 17, 2015
  • ViscusiERGimbelJSHalderAMA multiple-day regimen of parecoxib sodium 20 mg twice daily provides pain relief after total hip arthroplastyAnesth Analg2008107265266018633048
  • NussmeierNAWheltonAABrownMTSafety and efficacy of the cyclooxygenase-2 inhibitors parecoxib and valdecoxib after noncardiac surgeryAnesthesiology2006104351852616508400
  • HubbardRCNaumannTMTraylorLDhaddaSParecoxib sodium has opioid-sparing effects in patients undergoing total knee arthroplasty under spinal anaesthesiaBr J Anaesth200390216617212538372
  • MalanTPJrGordonSHubbardRSnabesMThe cyclooxygenase-2-specific inhibitor parecoxib sodium is as effective as 12 mg of morphine administered intramuscularly for treating pain after gynecologic laparotomy surgeryAnesth Analg2005100245446015673875
  • OttENussmeierNADukePCEfficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgeryJ Thorac Cardiovasc Surg200312561481149212830070
  • JoshiGPViscusiERGanTJEffective treatment of laparoscopic cholecystectomy pain with intravenous followed by oral COX-2 specific inhibitorAnesth Analg200498233634214742366
  • SnabesMCJakimiukAJKotarskiJParecoxib sodium administered over several days reduces pain after gynecologic surgery via laparotomyJ Clin Anesth200719644845517967675
  • RasmussenGLStecknerKHogueCTorriSHubbardRCIntravenous parecoxib sodium for acute pain after orthopedic knee surgeryAm J Orthop (Belle Mead NJ)200231633634312083587
  • BartonSFLangelandFFSnabesMCEfficacy and safety of intravenous parecoxib sodium in relieving acute postoperative pain following gynecologic laparotomy surgeryAnesthesiology200297230631412151917
  • BikhaziGBSnabesMCBajwaZHA clinical trial demonstrates the analgesic activity of intravenous parecoxib sodium compared with ketorolac or morphine after gynecologic surgery with laparotomyAm J Obstet Gynecol200419141183119115507939
  • DesjardinsPJGrossmanEHKussMEThe injectable cyclooxygenase-2-specific inhibitor parecoxib sodium has analgesic efficacy when administered preoperativelyAnesth Analg200193372172711524347
  • MalanTPJrMarshGHakkiSIParecoxib sodium, a parenteral cyclooxygenase 2 selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplastyAnesthesiology200398495095612657858
  • TangJLiSWhitePFEffect of parecoxib, a novel intravenous cyclooxygenase type-2 inhibitor, on the postoperative opioid requirement and quality of pain controlAnesthesiology20029661305130912170040
  • NussmeierNAWheltonAABrownMTComplications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgeryN Engl J Med2005352111081109115713945
  • ApfelbaumJLDesjardinsPJBrownMTVerburgKMMultiple-day efficacy of parecoxib sodium treatment in postoperative bunionectomy painClin J Pain200824978479218936596
  • DanielsSDGrossmanEHKussMEA Double-Blind, Randomized Comparison of Intramuscularly and Intravenously Administered Parecoxib Sodium Versus Ketorolac and Placebo in a Post-Oral Surgery Pain ModelClin Ther2001231018103111519767
  • MehlischDRDesjardinsPJDanielsSHubbardRCSingle doses of parecoxib sodium intravenously are as effective as ketorolac in reducing pain after oral surgeryJ Oral Maxillofac Surg2003619103012966478
  • MehlischDRDesjardinsPJDanielsSHubbardRCThe analgesic efficacy of intramuscular parecoxib sodium in postoperative dental painJ Am Dental Assoc200413515781590
  • AgrestiAHartzelJStrategies for comparing treatments on a binary response with multi-centre dataStat Med20001981115113910790684
  • MatsuiHShimokawaOKanekoTThe pathophysiology of non-steroidal anti-inflammatory drug (NSAID)-induced mucosal injuries in stomach and small intestineJ Clin Biochem Nutr201148210711121373261
  • HarrisRCCOX-2 and the kidneyJ Cardiovasc Pharmacol200647Suppl 1S37S4216785827
  • BakrMWallerDCOX-2 inhibitors and the cardiovascular system: is there a class effect?Br J Cardiol2005125387391
  • SchugSAJoshiGPCamuFPanSCheungRCardiovascular safety of the cyclooxygenase-2 selective inhibitors parecoxib and valdecoxib in the postoperative setting: an analysis of integrated dataAnesth Analg2009108129930719095866
  • LinYFYangCHSindyHSevere cutaneous adverse reactions related to systemic antibioticsClin Infect Dis201458101377138524599767
  • CastellsagueJRiera-GuardiaNCalingaertBIndividual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project)Drug Saf201235121127114623137151
  • LaporteJRIbanezLVidalXVendrellLLeoneRUpper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agentsDrug Saf200427641142015144234
  • BjarnasonIGastrointestinal safety of NSAIDs and over-the-counter analgesicsInt J Clin Pract Suppl201367s1783742
  • StoltzRRHarrisSIKussMEUpper GI mucosal effects of parecoxib sodium in healthy elderly subjectsAm J Gastroenterol2002971657111808971